Total Payments
$19,559
2024 Payments
$2,112
Companies
29
Transactions
206
Medicare Patients
3,107
Medicare Billing
$333,523
Payment Breakdown by Category
Food & Beverage$11,118 (56.8%)
Other$4,946 (25.3%)
Travel$3,295 (16.8%)
Education$200.69 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,118 | 186 | 56.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,596 | 2 | 23.5% |
| Travel and Lodging | $3,295 | 9 | 16.8% |
| Honoraria | $350.00 | 1 | 1.8% |
| Education | $200.69 | 8 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $7,926 | 37 | $0 (2024) |
| Merz North America, Inc. | $3,834 | 18 | $0 (2023) |
| ABBVIE INC. | $1,641 | 37 | $0 (2024) |
| Dermavant Sciences, Inc. | $708.24 | 9 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $705.48 | 12 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $645.76 | 5 | $0 (2024) |
| Biofrontera Inc. | $494.13 | 3 | $0 (2023) |
| Janssen Biotech, Inc. | $488.08 | 17 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $446.15 | 6 | $0 (2023) |
| PruGen, Inc. Pharmaceuticals | $290.06 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,112 | 35 | ABBVIE INC. ($881.24) |
| 2023 | $11,485 | 70 | Galderma Laboratories, L.P. ($7,084) |
| 2022 | $1,484 | 25 | Merz North America, Inc. ($838.43) |
| 2021 | $1,134 | 28 | SUN PHARMACEUTICAL INDUSTRIES INC. ($426.10) |
| 2020 | $321.52 | 7 | Lilly USA, LLC ($102.43) |
| 2019 | $915.74 | 16 | Galderma Laboratories, L.P. ($188.76) |
| 2018 | $826.19 | 11 | SANOFI-AVENTIS U.S. LLC ($280.30) |
| 2017 | $1,281 | 14 | Biofrontera Inc. ($484.29) |
All Payment Transactions
206 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $70.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $96.00 | General |
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $180.00 | General |
| Category: DERMATOLOGY | ||||||
| 10/25/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $30.90 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $31.78 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $149.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Immunology | ||||||
| 08/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $134.33 | General |
| Category: DERMATOLOGY | ||||||
| 07/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $138.00 | General |
| Category: Immunology | ||||||
| 07/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Immunology | ||||||
| 07/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: DERMATOLOGY | ||||||
| 06/28/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $136.36 | General |
| 06/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/10/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 06/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $58.91 | General |
| 06/03/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 04/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $94.71 | General |
| Category: Inflammation | ||||||
| 04/15/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 04/15/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 04/15/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 04/15/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 569 | 1,180 | $133,219 | $54,338 |
| 2022 | 8 | 534 | 1,163 | $122,885 | $49,378 |
| 2021 | 18 | 1,001 | 2,252 | $291,809 | $126,394 |
| 2020 | 17 | 1,003 | 4,752 | $279,940 | $103,413 |
Total Patients
3,107
Total Services
9,347
Medicare Billing
$333,523
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 151 | 250 | $35,520 | $17,724 | 49.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 114 | $24,004 | $11,591 | 48.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 57 | 77 | $20,020 | $7,578 | 37.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 108 | 154 | $25,530 | $6,765 | 26.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 46 | 57 | $12,312 | $4,355 | 35.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 86 | 441 | $6,492 | $2,663 | 41.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 17 | $6,003 | $2,409 | 40.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 18 | 27 | $3,240 | $1,218 | 37.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 43 | $98.47 | $35.93 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 219 | $31,116 | $15,282 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 105 | $22,109 | $10,471 | 47.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 57 | 76 | $19,760 | $6,794 | 34.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 110 | 150 | $24,867 | $6,715 | 27.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 18 | 29 | $10,240 | $4,189 | 40.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 90 | 498 | $7,331 | $3,061 | 41.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 33 | 34 | $7,344 | $2,819 | 38.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 52 | $119.08 | $47.92 | 40.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 162 | 238 | $50,113 | $24,361 | 48.6% |
| 96910 | Skin application of tar and ultraviolet b or petrolatum and ultraviolet b | Office | 2021 | 11 | 195 | $31,552 | $21,431 | 67.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 187 | 261 | $37,083 | $18,811 | 50.7% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2021 | 14 | 19 | $26,269 | $9,974 | 38.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 155 | 225 | $37,301 | $9,667 | 25.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 81 | 102 | $26,520 | $9,362 | 35.3% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 35 | 47 | $16,596 | $6,897 | 41.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 137 | 822 | $12,100 | $4,820 | 39.8% |
About Dr. Patrick Blake, MD
Dr. Patrick Blake, MD is a Dermatology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2010. The National Provider Identifier (NPI) number assigned to this provider is 1871817312.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Blake, MD has received a total of $19,559 in payments from pharmaceutical and medical device companies, with $2,112 received in 2024. These payments were reported across 206 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($11,118).
As a Medicare-enrolled provider, Blake has provided services to 3,107 Medicare beneficiaries, totaling 9,347 services with total Medicare billing of $333,523. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location San Diego, CA
- Active Since 03/25/2010
- Last Updated 01/18/2017
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1871817312
Products in Payments
- Xeomin (Biological) $3,223
- BOTOX (Biological) $986.98
- VTAMA (Drug) $708.24
- Sotyktu (Drug) $645.76
- Ameluz (Drug) $484.29
- TREMFYA (Drug) $460.68
- Ilumya (Biological) $401.18
- Otezla (Drug) $384.57
- DUPIXENT DUPILUMAB INJECTION (Biological) $292.88
- DUPIXENT (Drug) $284.43
- DUPIXENT (Biological) $191.43
- CIBINQO (Drug) $156.52
- ILUMYA (Biological) $143.17
- Tremfya (Drug) $140.31
- HUMIRA (Biological) $136.54
- TALTZ (Drug) $129.98
- ATOPIC DERMATITIS - DISEASE (Drug) $124.99
- EUCRISA (Drug) $123.02
- LIBTAYO (Biological) $120.96
- Erivedge (Biological) $107.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in San Diego
Dr. Sabrina Fabi, M.d, M.D
Dermatology — Payments: $3.3M
Dermatology $3.3M
Neal Bhatia, Md, MD
Dermatology — Payments: $2.6M
Dermatology $2.6M
Dr. Arisa Ortiz, M.d, M.D
Dermatology — Payments: $354,946
Dermatology $354,946
Dr. Dawn Eichenfield, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $179,796
Dermatology $179,796
Michael Bradshaw, M.d, M.D
Dermatology — Payments: $174,743
Dermatology $174,743
Dr. Tissa Hata, M.d, M.D
Dermatology — Payments: $138,047
Dermatology $138,047